> top > docs > PMC:3585731 > spans > 21245-21888 > annotations

PMC:3585731 / 21245-21888 JSONTXT

Annnotations TAB JSON ListView MergeView

testone

Id Subject Object Predicate Lexical cue
T30220 449-458 Negative_regulation denotes knockdown
T30219 343-353 Negative_regulation denotes inhibitors
T30218 519-523 Protein denotes TNFα
T30217 306-310 Protein denotes TNFα
T30216 153-157 Protein denotes bFGF
T30215 145-149 Protein denotes bFGF
T30214 45-49 Protein denotes TNFα

pmc-enju-pas

Id Subject Object Predicate Lexical cue
T30400 635-642 VB denotes plotted
T30399 631-634 VB denotes was
T30398 620-630 NN denotes average±SD
T30397 618-619 -COMMA- denotes ,
T30396 612-618 NN denotes graphs
T30395 608-611 DT denotes all
T30394 605-607 IN denotes In
T30393 592-603 NN denotes necroptosis
T30392 589-591 IN denotes of
T30391 578-588 NN denotes activation
T30390 572-577 IN denotes after
T30389 569-571 NN denotes hr
T30388 566-568 CD denotes 24
T30387 555-565 VB denotes determined
T30386 551-554 VB denotes was
T30385 541-550 NN denotes viability
T30384 536-540 NN denotes Cell
T30383 512-515 NN denotes fmk
T30382 510-512 CD denotes D.
T30381 507-510 IN denotes zVA
T30380 502-506 NN denotes with
T30379 500-502 CC denotes d
T30378 492-500 NN denotes r treate
T30377 488-492 IN denotes ot o
T30376 481-488 VB denotes tern bl
T30375 479-481 CC denotes es
T30374 475-479 NN denotes or w
T30373 468-475 JJ denotes ested f
T30372 465-468 IN denotes arv
T30371 456-465 VB denotes wn were h
T30370 452-456 VB denotes ckdo
T30369 443-452 NN denotes siRNA kno
T30368 438-443 NN denotes mTOR
T30367 433-437 NN denotes with
T30366 429-433 IN denotes lls
T30365 424-429 NN denotes 29 ce
T30364 420-424 NN denotes ) L9
T30363 419-420 -RRB- denotes D
T30362 418-419 NN denotes (
T30361 416-417 -LRB- denotes .
T30360 415-416 -RRB- denotes )
T30359 409-415 NN denotes PI-103
T30358 405-408 CC denotes and
T30357 397-404 NN denotes Torin-1
T30356 395-396 -COMMA- denotes ,
T30355 386-395 NN denotes rapamycin
T30354 385-386 -LRB- denotes (
T30353 380-384 NN denotes mTOR
T30352 376-379 CC denotes and
T30351 374-375 -RRB- denotes )
T30350 370-374 CD denotes VIII
T30349 365-368 NN denotes inh
T30348 361-364 NN denotes Akt
T30347 360-361 -LRB- denotes (
T30346 357-360 NN denotes Akt
T30345 354-356 IN denotes of
T30344 343-353 NN denotes inhibitors
T30343 340-342 IN denotes of
T30342 331-339 NN denotes presence
T30341 327-330 DT denotes the
T30340 324-326 IN denotes in
T30339 319-323 NN denotes cell
T30338 314-318 NN denotes L929
T30337 311-313 IN denotes in
T30336 306-310 NN denotes TNFα
T30335 303-305 CC denotes or
T30334 294-302 NN denotes zVAD.fmk
T30333 291-293 IN denotes by
T30332 283-290 VB denotes induced
T30331 279-282 VB denotes was
T30330 267-278 NN denotes Necroptosis
T30329 265-266 -RRB- denotes )
T30328 264-265 NN denotes C
T30327 263-264 -LRB- denotes (
T30326 251-262 NN denotes antibodies.
T30325 241-250 VB denotes indicated
T30324 237-240 DT denotes the
T30323 231-236 VB denotes using
T30322 222-230 NN denotes blotting
T30321 214-221 JJ denotes western
T30320 211-213 IN denotes by
T30319 202-210 VB denotes followed
T30318 200-201 -COMMA- denotes ,
T30317 196-200 NN denotes time
T30316 193-195 IN denotes of
T30315 185-192 NN denotes amounts
T30314 175-184 VB denotes indicated
T30313 171-174 DT denotes the
T30312 167-170 IN denotes for
T30311 153-166 NN denotes bFGF/zVAD.fmk
T30310 150-152 CC denotes or
T30309 145-149 NN denotes bFGF
T30308 140-144 IN denotes with
T30307 132-139 VB denotes treated
T30306 127-131 VB denotes were
T30305 117-126 NN denotes condition
T30304 112-116 JJ denotes free
T30303 106-111 NN denotes serum
T30302 100-105 IN denotes under
T30301 95-99 NN denotes Cell
T30300 93-94 -RRB- denotes )
T30299 92-93 NN denotes B
T30298 91-92 -LRB- denotes (
T30297 85-90 NN denotes blot.
T30296 77-84 JJ denotes western
T30295 73-76 IN denotes for
T30294 63-72 VB denotes harvested
T30293 59-62 CC denotes and
T30292 56-58 NN denotes hr
T30291 54-55 CD denotes 9
T30290 50-53 IN denotes for
T30289 45-49 NN denotes TNFα
T30288 42-44 CC denotes or
T30287 33-41 NN denotes zVAD.fmk
T30286 28-32 IN denotes with
T30285 20-27 VB denotes treated
T30284 15-19 VB denotes were
T30283 9-14 NN denotes cells
T30282 4-8 NN denotes L929
T30281 2-3 -RRB- denotes )
T30280 1-2 NN denotes A
T30279 0-1 -LRB- denotes (
R20940 T30280 T30279 arg2Of A,(
R20941 T30281 T30279 arg3Of ),(
R20942 T30283 T30279 arg1Of cells,(
R20943 T30283 T30282 arg1Of cells,L929
R20944 T30283 T30284 arg1Of cells,were
R20945 T30283 T30285 arg2Of cells,treated
R20946 T30285 T30284 arg2Of treated,were
R20947 T30285 T30286 arg1Of treated,with
R20948 T30287 T30288 arg1Of zVAD.fmk,or
R20949 T30288 T30286 arg2Of or,with
R20950 T30288 T30290 arg1Of or,for
R20951 T30289 T30288 arg2Of TNFα,or
R20952 T30292 T30290 arg2Of hr,for
R20953 T30292 T30291 arg1Of hr,9
R20954 T30294 T30293 arg2Of harvested,and
R20955 T30294 T30295 arg1Of harvested,for
R20956 T30294 T30302 arg1Of harvested,under
R20957 T30299 T30298 arg2Of B,(
R20958 T30300 T30298 arg3Of ),(
R20959 T30301 T30295 arg2Of Cell,for
R20960 T30301 T30296 arg1Of Cell,western
R20961 T30301 T30297 arg1Of Cell,blot.
R20962 T30301 T30298 arg1Of Cell,(
R20963 T30305 T30302 arg2Of condition,under
R20964 T30305 T30303 arg1Of condition,serum
R20965 T30305 T30304 arg1Of condition,free
R20966 T30307 T30306 arg2Of treated,were
R20967 T30307 T30308 arg1Of treated,with
R20968 T30307 T30318 arg1Of treated,","
R20969 T30307 T30319 modOf treated,followed
R20970 T30309 T30310 arg1Of bFGF,or
R20971 T30310 T30308 arg2Of or,with
R20972 T30310 T30312 arg1Of or,for
R20973 T30311 T30310 arg2Of bFGF/zVAD.fmk,or
R20974 T30315 T30312 arg2Of amounts,for
R20975 T30315 T30313 arg1Of amounts,the
R20976 T30315 T30314 arg2Of amounts,indicated
R20977 T30315 T30316 arg1Of amounts,of
R20978 T30317 T30316 arg2Of time,of
R20979 T30322 T30319 arg1Of blotting,followed
R20980 T30322 T30320 arg2Of blotting,by
R20981 T30322 T30321 arg1Of blotting,western
R20982 T30326 T30323 arg2Of antibodies.,using
R20983 T30326 T30324 arg1Of antibodies.,the
R20984 T30326 T30325 arg2Of antibodies.,indicated
R20985 T30326 T30327 arg1Of antibodies.,(
R20986 T30328 T30327 arg2Of C,(
R20987 T30329 T30327 arg3Of ),(
R20988 T30330 T30331 arg1Of Necroptosis,was
R20989 T30330 T30332 arg2Of Necroptosis,induced
R20990 T30332 T30331 arg2Of induced,was
R20991 T30334 T30335 arg1Of zVAD.fmk,or
R20992 T30335 T30332 arg1Of or,induced
R20993 T30335 T30333 arg2Of or,by
R20994 T30335 T30337 arg1Of or,in
R20995 T30335 T30340 arg1Of or,in
R20996 T30336 T30335 arg2Of TNFα,or
R20997 T30339 T30337 arg2Of cell,in
R20998 T30339 T30338 arg1Of cell,L929
R20999 T30342 T30340 arg2Of presence,in
R21000 T30342 T30341 arg1Of presence,the
R21001 T30342 T30343 arg1Of presence,of
R21002 T30342 T30345 arg1Of presence,of
R21003 T30344 T30343 arg2Of inhibitors,of
R21004 T30346 T30345 arg2Of Akt,of
R21005 T30349 T30347 arg2Of inh,(
R21006 T30349 T30348 arg1Of inh,Akt
R21007 T30350 T30351 arg1Of VIII,)
R21008 T30350 T30352 arg1Of VIII,and
R21009 T30352 T30370 modOf and,ckdo
R21010 T30353 T30352 arg2Of mTOR,and
R21011 T30353 T30354 arg1Of mTOR,(
R21012 T30355 T30356 arg1Of rapamycin,","
R21013 T30356 T30358 arg1Of ",",and
R21014 T30357 T30356 arg2Of Torin-1,","
R21015 T30358 T30354 arg2Of and,(
R21016 T30359 T30358 arg2Of PI-103,and
R21017 T30360 T30354 arg3Of ),(
R21018 T30362 T30361 arg2Of (,.
R21019 T30363 T30361 arg3Of D,.
R21020 T30365 T30361 arg1Of 29 ce,.
R21021 T30365 T30364 arg1Of 29 ce,) L9
R21022 T30365 T30366 arg1Of 29 ce,lls
R21023 T30365 T30370 arg1Of 29 ce,ckdo
R21024 T30365 T30371 arg2Of 29 ce,wn were h
R21025 T30365 T30376 arg2Of 29 ce,tern bl
R21026 T30369 T30366 arg2Of siRNA kno,lls
R21027 T30369 T30367 arg1Of siRNA kno,with
R21028 T30369 T30368 arg1Of siRNA kno,mTOR
R21029 T30371 T30372 arg1Of wn were h,arv
R21030 T30371 T30375 arg1Of wn were h,es
R21031 T30374 T30372 arg2Of or w,arv
R21032 T30374 T30373 arg1Of or w,ested f
R21033 T30375 T30370 arg2Of es,ckdo
R21034 T30376 T30375 arg2Of tern bl,es
R21035 T30376 T30377 arg1Of tern bl,ot o
R21036 T30376 T30381 arg1Of tern bl,zVA
R21037 T30378 T30379 arg1Of r treate,d
R21038 T30379 T30377 arg2Of d ,ot o
R21039 T30380 T30379 arg2Of with,d
R21040 T30383 T30381 arg2Of fmk,zVA
R21041 T30383 T30382 arg1Of fmk,D.
R21042 T30385 T30384 arg1Of viability,Cell
R21043 T30385 T30386 arg1Of viability,was
R21044 T30385 T30387 arg2Of viability,determined
R21045 T30387 T30386 arg2Of determined,was
R21046 T30387 T30390 arg1Of determined,after
R21047 T30389 T30388 arg1Of hr,24
R21048 T30390 T30389 arg1Of after,hr
R21049 T30391 T30390 arg2Of activation,after
R21050 T30391 T30392 arg1Of activation,of
R21051 T30393 T30392 arg2Of necroptosis,of
R21052 T30396 T30394 arg2Of graphs,In
R21053 T30396 T30395 arg1Of graphs,all
R21054 T30398 T30399 arg1Of average±SD,was
R21055 T30398 T30400 arg2Of average±SD,plotted
R21056 T30400 T30394 arg1Of plotted,In
R21057 T30400 T30397 arg1Of plotted,","
R21058 T30400 T30399 arg2Of plotted,was

bionlp-st-ge-2016-test-proteins

Id Subject Object Predicate Lexical cue
T30248 519-523 Protein denotes TNFα
T30247 306-310 Protein denotes TNFα
T30246 153-157 Protein denotes bFGF
T30245 145-149 Protein denotes bFGF
T30244 45-49 Protein denotes TNFα

bionlp-st-ge-2016-uniprot

Id Subject Object Predicate Lexical cue
T30559 438-442 http://www.uniprot.org/uniprot/P42345 denotes mTOR
T30558 380-384 http://www.uniprot.org/uniprot/P42345 denotes mTOR
T30557 361-364 http://www.uniprot.org/uniprot/Q9Y243 denotes Akt
T30556 357-360 http://www.uniprot.org/uniprot/Q9Y243 denotes Akt
T30555 361-364 http://www.uniprot.org/uniprot/P31751 denotes Akt
T30554 357-360 http://www.uniprot.org/uniprot/P31751 denotes Akt
T30553 361-364 http://www.uniprot.org/uniprot/P31749 denotes Akt
T30552 357-360 http://www.uniprot.org/uniprot/P31749 denotes Akt
T30551 153-157 http://www.uniprot.org/uniprot/Q788Q8 denotes bFGF
T30550 145-149 http://www.uniprot.org/uniprot/Q788Q8 denotes bFGF
T30549 519-523 http://www.uniprot.org/uniprot/P01375 denotes TNFα
T30548 306-310 http://www.uniprot.org/uniprot/P01375 denotes TNFα
T30547 45-49 http://www.uniprot.org/uniprot/P01375 denotes TNFα

UBERON-AE

Id Subject Object Predicate Lexical cue
T30233 106-111 http://purl.obolibrary.org/obo/UBERON_0001977 denotes serum

GO-BP

Id Subject Object Predicate Lexical cue
T30254 592-603 http://purl.obolibrary.org/obo/GO_0097528 denotes necroptosis
T30252 578-603 http://purl.obolibrary.org/obo/GO_0070266 denotes activation of necroptosis

GO-MF

Id Subject Object Predicate Lexical cue
T30255 251-261 http://purl.obolibrary.org/obo/GO_0003823 denotes antibodies

GO-CC

Id Subject Object Predicate Lexical cue
T30260 251-261 http://purl.obolibrary.org/obo/GO_0019815 denotes antibodies
T30259 536-540 http://purl.obolibrary.org/obo/GO_0005623 denotes Cell
T30258 427-432 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T30257 9-14 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T30261 251-261 http://purl.obolibrary.org/obo/GO_0042571 denotes antibodies

sentences

Id Subject Object Predicate Lexical cue
T30238 605-643 Sentence denotes In all graphs, average±SD was plotted.
T30237 536-604 Sentence denotes Cell viability was determined 24 hr after activation of necroptosis.
T30236 370-535 Sentence denotes VIII) and mTOR (rapamycin, Torin-1 and PI-103). (D) L929 cells with mTOR siRNA knockdown were harvested for western blot or treated with zVAD.fmk or TNFα for 24 hrs.
T30235 0-369 Sentence denotes (A) L929 cells were treated with zVAD.fmk or TNFα for 9 hr and harvested for western blot. (B) Cell under serum free condition were treated with bFGF or bFGF/zVAD.fmk for the indicated amounts of time, followed by western blotting using the indicated antibodies. (C) Necroptosis was induced by zVAD.fmk or TNFα in L929 cell in the presence of inhibitors of Akt(Akt inh.
T136 0-369 Sentence denotes (A) L929 cells were treated with zVAD.fmk or TNFα for 9 hr and harvested for western blot. (B) Cell under serum free condition were treated with bFGF or bFGF/zVAD.fmk for the indicated amounts of time, followed by western blotting using the indicated antibodies. (C) Necroptosis was induced by zVAD.fmk or TNFα in L929 cell in the presence of inhibitors of Akt(Akt inh.
T137 370-535 Sentence denotes VIII) and mTOR (rapamycin, Torin-1 and PI-103). (D) L929 cells with mTOR siRNA knockdown were harvested for western blot or treated with zVAD.fmk or TNFα for 24 hrs.
T138 536-604 Sentence denotes Cell viability was determined 24 hr after activation of necroptosis.
T139 605-643 Sentence denotes In all graphs, average±SD was plotted.

simple1

Id Subject Object Predicate Lexical cue
T30271 519-523 Protein denotes TNFα
T30270 306-310 Protein denotes TNFα
T30269 153-157 Protein denotes bFGF
T30268 145-149 Protein denotes bFGF
T30267 45-49 Protein denotes TNFα

BioNLP16_DUT

Id Subject Object Predicate Lexical cue
T30546 519-523 Protein denotes TNFα
T30545 306-310 Protein denotes TNFα
T30544 153-157 Protein denotes bFGF
T30543 145-149 Protein denotes bFGF
T30542 45-49 Protein denotes TNFα

BioNLP16_Messiy

Id Subject Object Predicate Lexical cue
T30574 519-523 Protein denotes TNFα
T30573 306-310 Protein denotes TNFα
T30572 153-157 Protein denotes bFGF
T30571 145-149 Protein denotes bFGF
T30570 45-49 Protein denotes TNFα

DLUT931

Id Subject Object Predicate Lexical cue
T30564 519-523 Protein denotes TNFα
T30563 306-310 Protein denotes TNFα
T30562 153-157 Protein denotes bFGF
T30561 145-149 Protein denotes bFGF
T30560 45-49 Protein denotes TNFα

bionlp-st-ge-2016-test-ihmc

Id Subject Object Predicate Lexical cue
T30629 145-149 Protein denotes bFGF
T30628 507-515 Entity denotes zVAD.fmk
T30627 251-261 Entity denotes antibodies
T30626 519-534 Protein denotes TNFα for 24 hrs
T30625 294-302 Entity denotes zVAD.fmk
T30624 386-395 Entity denotes rapamycin
T30623 153-157 Protein denotes bFGF
T30622 438-442 Protein denotes mTOR
T30621 357-360 Protein denotes Akt
T30620 409-415 Entity denotes PI-103
T30619 380-416 Protein denotes mTOR (rapamycin, Torin-1 and PI-103)
T30617 45-58 Protein denotes TNFα for 9 hr
T30616 95-126 Entity denotes Cell under serum free condition
T30615 422-458 Entity denotes L929 cells with mTOR siRNA knockdown
T30614 397-404 Entity denotes Torin-1
T30613 158-166 Entity denotes zVAD.fmk
T30612 370-374 Protein denotes VIII
T30611 33-41 Entity denotes zVAD.fmk
T30610 306-310 Protein denotes TNFα
T30609 361-364 Protein denotes Akt
T30608 343-353 Entity denotes inhibitors
T30607 528-534 Protein denotes 24 hrs
T30606 361-368 Entity denotes Akt inh
T30605 422-426 Entity denotes L929

bionlp-st-ge-2016-spacy-parsed

Id Subject Object Predicate Lexical cue
T30541 642-643 . denotes .
T30540 635-642 VBN denotes plotted
T30539 631-634 VBD denotes was
T30538 628-630 NNP denotes SD
T30537 627-628 NN denotes ±
T30536 620-627 JJ denotes average
T30535 618-619 , denotes ,
T30534 612-618 NNS denotes graphs
T30533 608-611 DT denotes all
T30532 605-607 IN denotes In
T30531 603-604 . denotes .
T30530 592-603 NN denotes necroptosis
T30529 589-591 IN denotes of
T30528 578-588 NN denotes activation
T30527 572-577 IN denotes after
T30526 569-571 NN denotes hr
T30525 566-568 CD denotes 24
T30524 555-565 VBN denotes determined
T30523 551-554 VBD denotes was
T30522 541-550 NN denotes viability
T30521 536-540 NNP denotes Cell
T30520 534-535 . denotes .
T30475 327-330 DT denotes the
T30474 324-326 IN denotes in
T30473 319-323 NN denotes cell
T30472 314-318 NNP denotes L929
T30471 311-313 IN denotes in
T30470 306-310 NNP denotes TNFα
T30469 303-305 CC denotes or
T30468 294-302 NNP denotes zVAD.fmk
T30467 291-293 IN denotes by
T30466 283-290 VBN denotes induced
T30465 279-282 VBD denotes was
T30464 267-278 NNP denotes Necroptosis
T30463 265-266 -RRB- denotes )
T30462 264-265 NNP denotes C
T30461 263-264 -LRB- denotes (
T30460 261-262 . denotes .
T30459 251-261 NNS denotes antibodies
T30458 241-250 VBN denotes indicated
T30457 237-240 DT denotes the
T30456 231-236 VBG denotes using
T30455 222-230 VBG denotes blotting
T30454 214-221 JJ denotes western
T30453 211-213 IN denotes by
T30452 202-210 VBN denotes followed
T30451 200-201 , denotes ,
T30450 196-200 NN denotes time
T30449 193-195 IN denotes of
T30448 185-192 NNS denotes amounts
T30447 175-184 JJ denotes indicated
T30446 171-174 DT denotes the
T30445 167-170 IN denotes for
T30444 163-166 NN denotes fmk
T30443 162-163 . denotes .
T30442 153-162 NNP denotes bFGF/zVAD
T30441 150-152 CC denotes or
T30440 145-149 NNP denotes bFGF
T30439 140-144 IN denotes with
T30438 132-139 VBN denotes treated
T30437 127-131 VBD denotes were
T30436 117-126 NN denotes condition
T30435 112-116 JJ denotes free
T30434 106-111 NN denotes serum
T30433 100-105 IN denotes under
T30432 95-99 NNP denotes Cell
T30431 93-94 -RRB- denotes )
T30430 92-93 NNP denotes B
T30429 91-92 -LRB- denotes (
T30428 89-90 . denotes .
T30427 85-89 NN denotes blot
T30426 77-84 JJ denotes western
T30425 73-76 IN denotes for
T30424 63-72 VBN denotes harvested
T30423 59-62 CC denotes and
T30422 56-58 NN denotes hr
T30421 54-55 CD denotes 9
T30420 50-53 IN denotes for
T30419 45-49 NNP denotes TNFα
T30418 42-44 CC denotes or
T30417 33-41 NNP denotes zVAD.fmk
T30416 28-32 IN denotes with
T30415 20-27 VBN denotes treated
T30414 15-19 VBD denotes were
T30413 9-14 NNS denotes cells
T30412 4-8 NNP denotes L929
T30411 2-3 -RRB- denotes )
T30410 1-2 NNP denotes A
T30409 0-1 -LRB- denotes (
T30519 531-534 NNS denotes hrs
T30518 528-530 CD denotes 24
T30517 524-527 IN denotes for
T30516 519-523 NNP denotes TNFα
T30515 516-518 CC denotes or
T30489 385-386 -LRB- denotes (
T30488 380-384 NNP denotes mTOR
T30487 376-379 CC denotes and
T30486 374-375 -RRB- denotes )
T30485 370-374 NNP denotes VIII
T30484 368-369 . denotes .
T30483 365-368 NN denotes inh
T30482 361-364 NNP denotes Akt
T30481 360-361 -LRB- denotes (
T30480 357-360 NNP denotes Akt
T30479 354-356 IN denotes of
T30478 343-353 NNS denotes inhibitors
T30477 340-342 IN denotes of
T30476 331-339 NN denotes presence
T30514 507-515 NNP denotes zVAD.fmk
T30513 502-506 IN denotes with
T30512 494-501 VBN denotes treated
T30511 491-493 CC denotes or
T30510 486-490 NN denotes blot
T30509 478-485 JJ denotes western
T30508 474-477 IN denotes for
T30507 464-473 VBN denotes harvested
T30506 459-463 VBD denotes were
T30505 449-458 NN denotes knockdown
T30504 443-448 NNP denotes siRNA
T30503 438-442 NNP denotes mTOR
T30502 433-437 IN denotes with
T30501 427-432 NNS denotes cells
T30500 422-426 NNP denotes L929
T30499 420-421 -RRB- denotes )
T30498 419-420 NNP denotes D
T30497 418-419 -LRB- denotes (
T30496 416-417 . denotes .
T30495 415-416 -RRB- denotes )
T30494 409-415 NNP denotes PI-103
T30493 405-408 CC denotes and
T30492 397-404 NNP denotes Torin-1
T30491 395-396 , denotes ,
T30490 386-395 NN denotes rapamycin
R21067 T30409 T30415 punct (,treated
R21068 T30410 T30413 nmod A,cells
R21069 T30411 T30410 punct ),A
R21070 T30412 T30413 compound L929,cells
R21071 T30413 T30415 nsubjpass cells,treated
R21072 T30414 T30415 auxpass were,treated
R21073 T30415 T30415 ROOT treated,treated
R21074 T30416 T30415 prep with,treated
R21075 T30417 T30416 pobj zVAD.fmk,with
R21076 T30418 T30417 cc or,zVAD.fmk
R21077 T30419 T30417 conj TNFα,zVAD.fmk
R21078 T30420 T30415 prep for,treated
R21079 T30421 T30422 nummod 9,hr
R21080 T30422 T30420 pobj hr,for
R21081 T30423 T30415 cc and,treated
R21082 T30424 T30415 conj harvested,treated
R21083 T30425 T30424 prep for,harvested
R21084 T30426 T30427 amod western,blot
R21085 T30427 T30425 pobj blot,for
R21086 T30428 T30415 punct .,treated
R21087 T30429 T30432 punct (,Cell
R21088 T30430 T30432 nmod B,Cell
R21089 T30431 T30432 punct ),Cell
R21090 T30432 T30438 nsubjpass Cell,treated
R21091 T30433 T30432 prep under,Cell
R21092 T30434 T30436 amod serum,condition
R21093 T30435 T30436 amod free,condition
R21094 T30436 T30433 pobj condition,under
R21095 T30437 T30438 auxpass were,treated
R21096 T30438 T30438 ROOT treated,treated
R21097 T30439 T30438 prep with,treated
R21098 T30440 T30439 pobj bFGF,with
R21099 T30441 T30440 cc or,bFGF
R21100 T30442 T30440 conj bFGF/zVAD,bFGF
R21101 T30443 T30438 punct .,treated
R21102 T30444 T30444 ROOT fmk,fmk
R21103 T30445 T30444 prep for,fmk
R21104 T30446 T30448 det the,amounts
R21105 T30447 T30448 amod indicated,amounts
R21106 T30448 T30445 pobj amounts,for
R21107 T30449 T30448 prep of,amounts
R21108 T30450 T30449 pobj time,of
R21109 T30451 T30444 punct ",",fmk
R21110 T30452 T30444 acl followed,fmk
R21111 T30453 T30452 agent by,followed
R21112 T30454 T30455 amod western,blotting
R21113 T30455 T30453 pobj blotting,by
R21114 T30456 T30452 advcl using,followed
R21115 T30457 T30459 det the,antibodies
R21116 T30458 T30459 amod indicated,antibodies
R21117 T30459 T30456 dobj antibodies,using
R21118 T30460 T30444 punct .,fmk
R21119 T30461 T30464 punct (,Necroptosis
R21120 T30462 T30464 nmod C,Necroptosis
R21121 T30463 T30464 punct ),Necroptosis
R21122 T30464 T30466 nsubjpass Necroptosis,induced
R21123 T30465 T30466 auxpass was,induced
R21124 T30466 T30466 ROOT induced,induced
R21125 T30467 T30466 agent by,induced
R21126 T30468 T30467 pobj zVAD.fmk,by
R21127 T30469 T30468 cc or,zVAD.fmk
R21128 T30470 T30468 conj TNFα,zVAD.fmk
R21129 T30471 T30466 prep in,induced
R21130 T30472 T30473 compound L929,cell
R21131 T30473 T30471 pobj cell,in
R21132 T30474 T30473 prep in,cell
R21133 T30475 T30476 det the,presence
R21134 T30476 T30474 pobj presence,in
R21135 T30477 T30476 prep of,presence
R21136 T30478 T30477 pobj inhibitors,of
R21137 T30479 T30478 prep of,inhibitors
R21138 T30480 T30479 pobj Akt,of
R21139 T30481 T30483 punct (,inh
R21140 T30482 T30483 compound Akt,inh
R21141 T30483 T30480 appos inh,Akt
R21142 T30484 T30466 punct .,induced
R21143 T30485 T30485 ROOT VIII,VIII
R21144 T30486 T30485 punct ),VIII
R21145 T30487 T30485 cc and,VIII
R21146 T30488 T30485 conj mTOR,VIII
R21147 T30489 T30490 punct (,rapamycin
R21148 T30490 T30485 appos rapamycin,VIII
R21149 T30491 T30490 punct ",",rapamycin
R21150 T30492 T30490 conj Torin-1,rapamycin
R21151 T30493 T30492 cc and,Torin-1
R21152 T30494 T30492 conj PI-103,Torin-1
R21153 T30495 T30492 punct ),Torin-1
R21154 T30496 T30485 punct .,VIII
R21155 T30497 T30501 punct (,cells
R21156 T30498 T30501 compound D,cells
R21157 T30499 T30500 punct ),L929
R21158 T30500 T30501 compound L929,cells
R21159 T30501 T30507 nsubjpass cells,harvested
R21160 T30502 T30501 prep with,cells
R21161 T30503 T30505 compound mTOR,knockdown
R21162 T30504 T30505 compound siRNA,knockdown
R21163 T30505 T30502 pobj knockdown,with
R21164 T30506 T30507 auxpass were,harvested
R21165 T30507 T30507 ROOT harvested,harvested
R21166 T30508 T30507 prep for,harvested
R21167 T30509 T30510 amod western,blot
R21168 T30510 T30508 pobj blot,for
R21169 T30511 T30507 cc or,harvested
R21170 T30512 T30507 conj treated,harvested
R21171 T30513 T30512 prep with,treated
R21172 T30514 T30513 pobj zVAD.fmk,with
R21173 T30515 T30514 cc or,zVAD.fmk
R21174 T30516 T30514 conj TNFα,zVAD.fmk
R21175 T30517 T30512 prep for,treated
R21176 T30518 T30519 nummod 24,hrs
R21177 T30519 T30517 pobj hrs,for
R21178 T30520 T30507 punct .,harvested
R21179 T30521 T30522 compound Cell,viability
R21180 T30522 T30524 nsubjpass viability,determined
R21181 T30523 T30524 auxpass was,determined
R21182 T30524 T30524 ROOT determined,determined
R21183 T30525 T30526 nummod 24,hr
R21184 T30526 T30527 npadvmod hr,after
R21185 T30527 T30524 prep after,determined
R21186 T30528 T30527 pobj activation,after
R21187 T30529 T30528 prep of,activation
R21188 T30530 T30529 pobj necroptosis,of
R21189 T30531 T30524 punct .,determined
R21190 T30532 T30540 prep In,plotted
R21191 T30533 T30534 det all,graphs
R21192 T30534 T30532 pobj graphs,In
R21193 T30535 T30540 punct ",",plotted
R21194 T30536 T30537 amod average,±
R21195 T30537 T30538 compound ±,SD
R21196 T30538 T30540 nsubjpass SD,plotted
R21197 T30539 T30540 auxpass was,plotted
R21198 T30540 T30540 ROOT plotted,plotted
R21199 T30541 T30540 punct .,plotted

bionlp-st-ge-2016-test-tees

Id Subject Object Predicate Lexical cue
T30589 449-458 Negative_regulation denotes knockdown
T30579 163-166 Protein denotes fmk
T30578 153-162 Protein denotes bFGF/zVAD
T30588 507-523 Protein denotes zVAD.fmk or TNFα
T30587 438-448 Protein denotes mTOR siRNA
T30586 343-353 Negative_regulation denotes inhibitors
T30585 343-353 Negative_regulation denotes inhibitors
T30584 343-353 Negative_regulation denotes inhibitors
T30583 380-384 Protein denotes mTOR
T30582 361-364 Protein denotes Akt
T30581 357-360 Protein denotes Akt
T30580 294-310 Protein denotes zVAD.fmk or TNFα
T30577 145-149 Protein denotes bFGF
T30576 33-49 Protein denotes zVAD.fmk or TNFα
R21200 T30581 T30584 themeOf Akt,inhibitors
R21201 T30582 T30585 themeOf Akt,inhibitors
R21202 T30583 T30586 themeOf mTOR,inhibitors
R21203 T30587 T30589 themeOf mTOR siRNA,knockdown

test3

Id Subject Object Predicate Lexical cue
T30232 519-523 Protein denotes TNFα
T30231 343-353 Negative_regulation denotes inhibitors
T30230 306-310 Protein denotes TNFα
T30229 283-290 Positive_regulation denotes induced
T30228 153-157 Protein denotes bFGF
T30227 145-149 Protein denotes bFGF
T30226 45-49 Protein denotes TNFα
T30225 519-523 Protein denotes TNFα
T30224 306-310 Protein denotes TNFα
T30223 153-157 Protein denotes bFGF
T30222 145-149 Protein denotes bFGF
T30221 45-49 Protein denotes TNFα
R20933 T30231 T30229 causeOf inhibitors,induced